Primary Treatment of Uterine Sarcomas

Gynecologic Cancer: Controversies in Management

Volumn , Issue , 2004, Pages 301-316

  Winter, Raimund ^a,b   Östör, Andrew G ^b   Kapp, Karin ^a   Petru, Edgar ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b Department of Obstetrics and Gynecology ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29144515890     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-07142-3.50026-9     Document Type: Chapter

References (128)

1. FA Tavassoli and P Devilee (Eds) (2003) Pathology and Genetics of Tumours of the Breast and Female Genital Organs Lyon: IARC Press 218.
2. RR Nordal, GB Kristensen, AE Stenwig, et al. (1997) An evaluation of prognostic factors in uterine carcinosarcoma. Gynecol Oncol 3 316-321.
3. WG McCluggage, M Abdulkader, JH Price, et al. (2000) Uterine carcinosarcomas in patients receiving tamoxifen: A report of 19 cases. Int J Gynecol Cancer 10 280-284.
4. T Treilleux, H Mignotte, C Clement-Chassagne, et al. (1999) Tamoxifen and malignant epithelial-nonepithelial tumors of the endometrium: report of six cases and review of the literature. Eur Surg Oncol 25 477-482.
5. JC Chumas, WJ Mann and L Tseng (1983) Malignant mixed mullerian tumor of the endometrium in a young woman with polycystic ovaries. Cancer 52 1478-1481.
6. A Gaducci, F Landoni, E Sartori, et al. (1996) Uterine leiomyosarcoma: Analysis of treatment failures and survival. Gynecol Oncol 62 25-32.
7. FJ Major, JA Blessing, SG Silverberg, et al. (1993) Prognostic factors in early-stage uterine sarcoma: A Gynaecologic Oncology Group study. Cancer 71 1702-1709.
8. BL Harlow, NS Weiss and S Lofton (1986) The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 76 399-402.
9. T Madison, D Schottenfeld and V Baker (1998) Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: An analysis in trends in incidence and mortality and their relation to histologic subtype and stage. Cancer 83 1546-1554.
10. HJ Norris and HB Taylor (1966) Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 19 755-766.
11. FA Tavassoli and HJ Norris (1981) Mesenchymal tumors of the uterus VII: A clinicopathologic study of 60 endometrial stroma nodules. Histopathology 5 1-10.
12. KL Chang, GS Crabtree, SK Lim-Tan, et al. (1990) Primary uterine endometrial stroma neoplasms: A clinicopathologic study of 117 cases. Am J Surg Pathol 14 415-438.
13. HL Evans (1982) Endometrial stroma sarcoma and poorly differentiated endometrial sarcoma. Cancer 50 2170-2182.
14. E Oliva, PB Clement, RH Young and RE Scully (1998) Mixed endometrial stroma and smooth muscle tumors of the uterus: A clinicopathologic study of 15 cases. Am J Surg Pathol 22 997-1005.
15. DP Schammel, SA Silver and FA Tavassoli (1999) Combined endometrial stromal/smooth muscle neoplasms of the uterus: Clinicopathologic study of 38 cases. Mod Pathol 12 124A.
16. HT Norris and HB Taylor (1966) Polyps of the vagina: A benign lesion resembling sarcoma botryoides. Cancer 19 227-232.
17. MR Nucci, RH Young and CD Fletcher (2000) Cellular pseudosarcomatous fibroepithelial stromal polyps of the lower female genital tract: An underrecognized lesion often misdiagnosed as sarcoma. Am J Surg Pathol 24 231-240.
18. AG Östör, DW Fortune and CB Riley (1988) Fibroepithelial polyps with atypical stromal cells (pseudosarcoma botryoides) of the vulva and vagina: A report of 13 cases. Int J Gynecol Pathol 7 351-360.
19. DM Parham (2001) Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14 506-514.
20. DA Daya and RE Scully (1988) Sarcoma botryoides of the uterine cervix in young women: A clinicopathological study of 13 cases. Gynecol Oncol 29 290-304.
21. PB Clement and RE Scully (1990) Müllerian adenosarcoma of the uterus: A clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21 363-381.
22. AG Östör and DW Fortune (1980) Benign and low grade variants of mixed mullerian tumor of the uterus. Histopathology 4 369-382.
23. KS Olah, JA Dunn and H Gee (1992) Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumors when adjusting for known prognostic factors: The result of a retrospective study of 423 cases of uterine sarcoma. Br J Obstet Gynaecol 99 590-594.
24. BM Ronnett, RJ Zaino, LH Elenson and RJ Kurman (2002) Endometrial carcinoma. RJ Kurman (Eds) Blaustein's Pathology of the Female Genital Tract 5th ed. New York: Springer-Verlag 538-541.
25. REN Van Rijswijk, G Tognon, CW Burger, et al. (1994) The effect of chemotherapy on the differential components of advanced carcinosarcomas (malignant mixed mesedermal tumors) of the female genital tract. Int J Gynecol Cancer 4 52-60.
26. AG Östör and TP Roccason (2002) Mixed tumors of the uterus. H Fox, M Wells (Eds) Haines and Taylor Obstetrical and Gynaecological Pathology 5th ed. Edinburgh: Elsevier Science
27. A Zelmanowicz, A Hildesheim, ME Sherman, et al. (1998) Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. Gynecol Oncol 69 253-257.
28. E George, TJ Lillemoe, LB Twiggs and T Perrone (1995) Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: A comparative analysis of survival. Int J Gynecol Pathol 14 39-44.
29. AA Liebow and B Castleman (1971) Benign clear cell (“sugar”) tumors of the lung. Yale J Biol Med 43 213-222.
30. M Pea, G Martignoni, G Zamboni and F Bonetti (1996) Perivascular epithelioid cell. Am J Surg Pathol 20 1149-1155.
31. R Vang and RL Kempson (2002) Perivascular epithelioid cell tumor (“PEComa”) of the uterus: A subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol 26 1-13.
32. FT Kraus (1967) Gynecologic Pathology St Louis: CV Mosby
33. S Leibsohn, G d'Ablaing, DR Mishell and JB Schlaerth (1990) Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 162 968-976.
34. BA Goff, LW Rice, D Fleischhacker, et al. (1993) Uterine leiomyosarcoma and endometrial stroma sarcoma: Lymph node metastases and sites of recurrence. Gynecol Oncol 50 105-109.
35. WH Parker, YS Fu and JS Berek (1994) Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83 414-418.
36. A Kurjak, S Kupesic, H Shalan, et al. (1995) Uterine sarcoma: A report of 10 cases studied by transvaginal color and pulsed Doppler sonography. Gynecol Oncol 59 342-346.
37. N Umesaki, T Tanaka, M Miyama, et al. (2001) Positron emission tomography with F-fluorodeoxyglucose of uterine sarcoma: A comparison with magnetic resonance imaging and power Doppler imaging. Gynecol Oncol 80 372-377.
38. R Blom, C Guerrieri, O Stal, et al. (1998) Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases. Gynecol Oncol 68 54-61.
39. KV Kahanpaa, T Wahlstrom, P Grohn, et al. (1986) Sarcomas of the uterus: A clinicopathologic study of 119 patients. Obstet Gynecol 67 417-424.
40. MJ Marchese, AS Liskow, CP Crum, et al. (1984) Uterine sarcomas: A clinicopathologic study, 1965-1981. Gynecol Oncol 18 299-312.
41. M Nola, D Babic, J Ilic, et al. (1996) Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer 78 2543-2550.
42. RR Nordal, GB Kristensen, J Kaern, et al. (1995) The prognostic significance of stage, tumor size, cellular atypia and DAN ploidy in uterine leiomyosarcoma. Acta Oncol 34 797-802.
43. AH Wolfson, DJ Wolfson, SY Sittler, et al. (1994) A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 52 56-62.
44. B Larson, C Silfversward, B Nilsson and F Petterson (1990) Prognostic factors in uterine leiomyosarcoma: A clinicopathologic study of 143 cases. The /?Radiumhemmet series, 1936-1981. Acta Oncol 29 185-191.
45. P Pautier, C Genestie, A Rey, et al. (2000) Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88 1425-1431.
46. HL Evans, SP Chawla, C Simpson and KP Finn (1988) Smooth muscle neoplasms of the uterus other than ordinary leiomyoma: A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 62 2239-2247.
47. K Mayerhofer, A Obermair, G Windbichler, et al. (1999) Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases. Gynecol Oncol 74 196-201.
48. JR Vardi and HMM Tovell (1980) Leiomyosarcoma of the uterus: A clinicopathologic study. Obstet Gynecol 56 428-434.
49. JF Barter, EB Smith, CA Szap, et al. (1985) Leiomyosarcoma of the uterus: Clinicopathologic study of 21 cases. Gynecol Oncol 21 220-227.
50. WR Hart and JK Billman Jr (1978) A reassessment of uterine neoplasms originally diagnosed as leiomyosarcomas. Cancer 41 1902-1910.
51. AK El-Naggar, FW Abdul-Karim, EG Silva, et al. (1991) Uterine stromal neoplasms: A clinicopathologic and DNA flow cytometric correlation. Hum Pathol 22 897-903.
52. K Bodner, B Bodner-Adler, A Obermair, et al. (2001) Prognostic parameters in endometrial stroma sarcoma: A clinicopathologic study in 31 patients. Gynecol Oncol 81 160-165.
53. RL Bekkers, WN Willemsen, CP Schijf, et al. (1999) Leiomyomatosis peritonealis disseminata: Does malignant transformation occur? A literature review. Gynecol Oncol 75 158-163.
54. R Blom and C Guerrieri (1999) Adenosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 11 cases. Int J Gynecol Cancer 9 37-43.
55. GL Eddy and MT Mazur (1997) Endolymphatic stromal myosis associated with tamoxifen use. Gynecol Oncol 64 262-264.
56. Fukunaga M, Ishihara A, Ushigome S: Extrauterine low-grade endometrial stromal sarcoma: Report of three cases. Pathol Int 198;48:297-302.
57. J Ordi, MD Stamatakos and FA Tavassoli (1997) Pure pleomorphic rhabdomyosarcomas of the uterus. Int J Gynecol Pathol 16 369-377.
58. BJ Quade, AP Pinto, DR Howard, et al. (1999) Frequent loss of heterozygosity of chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma. Am J Pathol 154 945-950.
59. E Roth and HB Taylor (1966) Heterologic cartilage in the uterus. Obstet Gynecol 27 838-844.
60. L Tietze, K Guenther, A Hoerbe, et al. (2000) Benign metastasizing leiomyoma: A cytogenetically balanced but clonal disease. Hum Pathol 31 126-128.
61. K Tsushima, CR Stanhope, TA Gaffey and MM Lieber (1988) Uterine leiomyosarcomas and benign smooth muscle tumors: Usefulness of nuclear DNA patterns studied by flow cytometry. Mayo Clin Proc 63 248-255.
62. C Marth, G Windbichler, E Petru, et al. (1997) Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium. Gynecol Oncol 64 121-125.
63. F Girardi, E Petru, M Heydarfadai, et al. (1993) Pelvic lymphadenectomy in surgical treatment of endometrial cancer. Gynecol Oncol 49 177-180.
64. SS Chen (1989) Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus. Gynecol Oncol 32 215-218.
65. WP Fleming, WA Peters, NB Kumar and GW Morley (1984) Autopsy findings in patients with uterine sarcoma. Gynecol Oncol 19 168-172.
66. PG Rose, MS Piver, Y Tsukada and T Lau (1989) Patterns of metastasis in uterine sarcoma: An autopsy study. Cancer 63 935-938.
67. A Berchuck, SC Rubin, WJ Hoskins, et al. (1988) Treatment of uterine leiomyosarcoma. Obstet Gynecol 71 845-850.
68. GB Gard, NJ Mulvany and MA Quinn (1999) Management of uterine leiomyosarcoma in Australia. Aust N Z J Obstet Gynaecol 39 93-98.
69. T Van Dinh and JD Woodruff (1982) Leimyosarcoma of the uterus. Am J Obstet Gynecol 144 817-823.
70. NR Abu-Rustum, JP Curtin, M Burt and WB Jones (1997) Regression of uterine low-grade smooth muscle tumors metastatic to the lung after oophorectomy. Obstet Gynecol 89 850-852.
71. LB Schwartz, MP Diamond and PE Schwartz (1993) Leiomyosarcomas: clinical presentation. Am J Obstet Gynecol 168 180-183.
72. C Levenback, SC Rubin, PM McCormack, et al. (1992) Resection of pulmonary metastases from uterine sarcomas. Gynecol Oncol 45 202-205.
73. Morrow CP: Leiomyosarcoma. In Morrow CP, Curtin JP (eds): Gynecologic Cancer Surgery. New York, 1996, pp. 613-616.
74. AL Covens, JA Nisker, WB Chapman and HH Allen (1987) Uterine sarcoma: An analysis of 74 cases. Am J Obstet Gynecol 156 370-374.
75. P.J. Di Saia PhJ, CP Morrow, R Boronow, et al. (1978) Endometrial sarcoma: Lymphatic spread pattern. Am J Obstet Gynecol 130 104-105.
76. OM Salazar, TA Bonfiglio, SF Patten, et al. (1978) Uterine sarcomas: Analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 42 1161-1170.
77. EM Swisher, AM Gown, M Skelly, et al. (1996) The expression of epidermal growth factor receptor, HER-2/Neu, p53 and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma. Gynecol Oncol 60 81-88.
78. T Kaku, SG Silverberg, FJ Major, et al. (1992) Adenosarcoma of the uterus: A Gynecologic Oncology Group clinicopathologic study of 31 cases. Int J Gynecol Pathol 11 75-88.
79. JD Seidman, CS Wasserman, LM Aye, et al. (1999) Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth. Am J Surg Pathol 23 809-814.
80. R Gollard, M Kosty, G Bordin, et al. (1995) Two unusual presentations of müllerian adenosarcoma: Case reports, literature review, and treatment considerations. Gynecol Oncol 59 412-422.
81. E George, JC Manivel, LP Dehner and MR Wick (1991) Malignant mixed müllerian tumors: An immunochemical study of 47 cases, with histogenetic consideration and clinical correlation. Hum Pathol 22 215-223.
82. B Sorbe (1985) Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas. Gynecol Oncol 20 281-289.
83. M George, MH Pejovic, A Kramar and Gynecologic Cooperating Group of French Oncology Centers (1986) Uterine sarcomas: Prognostic factors and treatment modalities—Study on 209 patients. Gynecol Oncol 24 58-67.
84. G Omura, J Blessing, F Major, et al. (1985) A randomized clinical trial of adjuvant Adriamycin in uterine sarcomas: A Gynecologic Oncology Group study. J Clin Oncol 3 1240-1245.
85. NB Hornback, G Omura and FJ Major (1986) Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys 12 2127-2130.
86. B Jereczek, J Jassem and A Kobierska (1996) Sarcoma of the uterus: A clinical study of 42 pts. Arch Gynecol Obstet 258 171-180.
87. SD Tinkler and VJ Cowie (1993) Uterine sarcomas: A review of the Edinburgh experience from 1974 to 1992. Br J Radiol 66 998-1001.
88. PG Rose, JG Boutselis and L Sachs (1987) Adjuvant therapy for stage I uterine sarcoma. Am J Obstet Gynecol 156 660-662.
89. L Chauveinc, E Deniaud, C Plancher, et al. (1999) Uterine sarcomas— The Curie Institut experience: Prognosis factors and adjuvant treatments. Gynecol Oncol 72 232-237.
90. G Echt, J Jepson, J Steel, et al. (1990) Treatment of uterine sarcomas. Cancer 66 35-39.
91. F Ferrer, S Sabater, B Farrus, et al. (1999) Impact of radiotherapy on local control and survival in uterine sarcomas: A retrospective study from the Group Oncologic Catala-Occita. Int J Radiat Oncol Biol Phys 44 47-52.
92. E Moskovic, E Macsweeney, M Law and A Price (1993) Survival, patterns of spread and prognostic factors in uterine sarcoma: A study of 76 patients. Br J Radiol 66 1009-1015.
93. TH Knocke, H Kucera, D Dörfler, et al. (1989) Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer 83 1972-1979.
94. SN Nielsen, KC Podratz, BW Scheithauer and PC O'Brien (1989) Clinicopathologic analysis of uterine malignant mixed müllerian tumors. Gynecol Oncol 34 372-378.
95. DS Chi, B Mychalczak, PE Saigo, et al. (1997) The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecol Oncol 65 493-498.
96. K Gerszten, C Faul, S Kounelis, et al. (1998) The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol 68 8-13.
97. TP Manolitsas, GV Wain, KE Williams, et al. (2001) Multimodality therapy for patients with clinical stage I and II malignant mixed müllerian tumors of the uterus. Cancer 91 1437-1443.
98. HD Weitmann, H Kucera, TH Knocke and R Pötter (2002) Surgery and adjuvant radiation therapy of endometrial stromal sarcoma. Wien Klin Wochenschr 114 1-2.
99. CA Perez, F Askin, RJ Baglan, et al. (1979) Effects of irradiation on mixed müllerian tumors of the uterus. Cancer 43 1274-1284.
100. RR Nordal and SO Thoresen (1997) Uterine sarcomas in Norway 1956-1992: Incidence, survival and mortality. Eur J Cancer 33 907-911.
101. WA Peters III, SE Rivkin, MR Smith and DE Tesh (1989) Cisplatin and Adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors. Gynecol Oncol 34 323-327.
102. J Currie, J Blessing, H Muss, et al. (1996) Combination chemotherapy with hydroxyurea, dacarbazine, and etoposide in the treatment of uterine leiomyosarcoma: A Gynecologic Oncology Group study. Gynecol Oncol 61 27-30.
103. S Leyvraz, M Bacchi, A Lissoni, et al. (1998) High response rate with the combination of high-dose ifosfamide and doxorubicin for the treatment of advanced gynecologic sarcomas. Proc ASCO 17 354a.
104. G Sutton, J Blessing, R Barrett and R McGehee (1992) Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: A Gynecologic Oncology Group study. Am J Obstet Gynecol 166 556-559.
105. G Sutton, J Blessing and H Ball (1999) Phase II trial of paclitaxel in leiomyosarcoma of the uterus: A Gynecologic Oncology Group study. Gynecol Oncol 74 346-349.
106. T Thigpen, J Blessing, J Beecham, et al. (1991) Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: A Gynecologic Oncology Group study. J Clin Oncol 9 1962-1966.
107. G Sutton, J Blessing, R Park, et al. (1996) Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: A study of the Gynecologic Oncology Group. Obstet Gynecol 87 747-750.
108. G Sutton, J Blessing and J Malfetano (1996) Ifosfamide and doxorubicin in the treatment advanced leiomyosarcomas of the uterus: A Gynecologic Oncology Group study. Gynecol Oncol 62 226-229.
109. G Omura, F Major, J Blessing, et al. (1983) A randomized study of Adriamycin with or without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 52 626-632.
110. A Berchuck, S Rubin, W Hoskins, et al. (1990) Treatment of endometrial stromal tumors. Gynecol Oncol 36 60-65.
111. A Mesia and R Demopoulos (2000) Effects of leuprolide acetate on low-grade endometrial stromal sarcoma. Am J Obstet Gynecol 182 1140-1141.
112. F Maluf, P Sabbatini, L Schwartz, et al. (2001) Endometrial stromal sarcoma: Objective response to letrozole. Gynecol Oncol 82 384-388.
113. G Sutton, J Blessing, L Carson, et al. (1997) Adjuvant ifosfamide, mesna, and cisplatin in patients with completely resected stage I or II carcinosarcoma of the uterus: A study of the Gynecologic Oncology Group. Proc ASCO 16 362a.
114. G Sutton, V Brunetto, L Kilgore, et al. (1998) A phase III trial of ifosfamide alone or in combination with cisplatin in the treatment of advanced, persistent, or recurrent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study. Gynecol Oncol 68 137-141.
115. E Hannigan, R Freedman, K Elder and F Rutledge (1983) Treatment of advanced uterine sarcoma with Adriamycin. Gynecol Oncol 16 101-104.
116. J Fowler, J Blessing, R Burger and J Malfetano (2002) Phase II evaluation of oral trimetrexate in mixed mesodermal tumors of the uterus: A Gynecologic Oncology Group Study. Gynecol Oncol 85 311-314.
117. Y Shimizu (2000) Combination of consecutive low-dose cisplatin with ifosfamide and epirubicin for sarcoma uteri. Proc ASCO 19 391a.
118. M Hensley, E Venkatrama, R Maki and D Spriggs (2001) Docetaxel plus gemcitabine is active in leimyosarcoma: Results of a phase II trial. Proc ASCO 20 353a.
119. A Lissoni, G Cormio, N Colombo, et al. (1997) High-dose epirubicin in patients with advanced or recurrent uterine sarcoma. Int J Gynecol Cancer 7 241-244.
120. S Piver and P Rose (1988) Advanced uterine sarcoma: Response to chemotherapy. Eur J Gynaecol Oncol 9 124-129.
121. H Muss, B Bundy, P DiSaia, et al. (1985) Treatment of recurrent or advanced uterine sarcoma. Cancer 55 1648-1653.
122. R Hawkins, E Wiltshaw and J Mansi (1990) Ifosfamide with and without adriamycin in advanced uterine leiomyosarcoma. Cancer Chemother Pharmacol 26(Suppl), 26-29.
123. T Thigpen, J Blessing and G Wilbanks (1986) Cisplatin as second-line chemotherapy in the treatment of advanced or recurrent leiomyosarcoma of the uterus: A phase II trial of the Gynecologic Oncology Group. Am J Clin Oncol 9 18-20.
124. D Gershenson, J Kavanagh, L Copeland, et al. (1987) Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterus. J Clin Oncol 5 618-621.
125. G Sutton, J Blessing, N Rosenshein, et al. (1989) Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus. Am J Obstet 161 309-312.
126. T Thigpen, J Blessing, J Orr and P DiSaia (1986) Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: A Gynecologic Oncology Group study. Cancer Treat Rep 70 271-274.
127. J Currie, J Blessing, R McGhee, et al. (1996) Phase II trial of hydroxyurea, dacarbazine, and etoposide in mixed mesodermal tumors of the uterus: A Gynecologic Oncology Group study. Gynecol Oncol 61 94-96.
128. D Gershenson, J Kavanagh, L Copeland, et al. (1987) High-dose doxorubicin infusion therapy for disseminated mixed mesodermal sarcoma of the uterus. Cancer 59 1264-1267.